DarioHealth Corp. Cost of Revenue
DarioHealth Corp. (DRIO) reported Cost of Revenue of $652.00 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2016-11-10
- DarioHealth Corp. cost of revenue for the quarter ending 2016-09-30 was $652.00K, a 61.39% increase year-over-year.
- DarioHealth Corp. cost of revenue for the quarter ending 2016-06-30 was $826.00K, a 101.46% increase year-over-year.
- DarioHealth Corp. cost of revenue for the quarter ending 2016-03-31 was $670.00K, a 125.59% increase year-over-year.
- DarioHealth Corp. cost of revenue for the quarter ending 2015-12-31 was $567.00K, a 14.48% decline year-over-year.
- DarioHealth Corp. cost of revenue for fiscal 2015 was $1.68M, a 26.21% decline from fiscal 2014.
- DarioHealth Corp. cost of revenue for fiscal 2014 was $2.27M.
- DarioHealth Corp. cost of revenue for fiscal 2013 was $0.00.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2016-09-30 | $652.00K 10-Q · filed 2016-11-10 | $1.48M derived: sum of 2 quarters · filed 2016-11-10 | $2.15M 10-Q · filed 2016-11-10 | $2.71M derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-06-30 | $826.00K 10-Q · filed 2016-08-11 | $1.50M 10-Q · filed 2016-08-11 | $2.06M derived: sum of 3 quarters · filed 2016-08-11 | $2.47M derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-03-31 | $670.00K 10-Q · filed 2016-05-11 | $1.24M derived: sum of 2 quarters · filed 2016-05-11 | $1.64M derived: sum of 3 quarters · filed 2016-11-10 | $2.05M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-12-31 | $567.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-08 | $971.00K derived: sum of 2 quarters · filed 2016-11-10 | $1.38M derived: sum of 3 quarters · filed 2016-11-10 | $1.68M 10-K · filed 2016-02-08 |
| 2015-09-30 | $404.00K 10-Q · filed 2016-11-10 | $814.00K derived: sum of 2 quarters · filed 2016-11-10 | $1.11M 10-Q · filed 2016-11-10 | $1.77M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $410.00K 10-Q · filed 2016-08-11 | $707.00K 10-Q · filed 2016-08-11 | $1.37M derived: sum of 3 quarters · filed 2016-08-11 | $1.96M derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | $297.00K 10-Q · filed 2016-05-11 | $960.00K derived: sum of 2 quarters · filed 2016-05-11 | $1.54M derived: sum of 3 quarters · filed 2016-05-11 | $2.15M derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | $663.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-08 | $1.25M derived: sum of 2 quarters · filed 2016-02-08 | $1.85M derived: sum of 3 quarters · filed 2016-02-08 | $2.27M 10-K · filed 2016-02-08 |
| 2014-09-30 | $585.00K 10-Q · filed 2015-11-13 | $1.19M derived: sum of 2 quarters · filed 2015-11-13 | $1.61M 10-Q · filed 2015-11-13 | $1.61M derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | $605.00K 10-Q · filed 2015-08-12 | $1.03M 10-Q · filed 2015-08-12 | $1.03M derived: sum of 3 quarters · filed 2015-08-12 | $1.03M derived: sum of 4 quarters · filed 2015-08-12 |
| 2014-03-31 | $421.00K 10-Q · filed 2015-05-14 | $421.00K derived: sum of 2 quarters · filed 2015-05-14 | $421.00K derived: sum of 3 quarters · filed 2015-05-14 | $421.00K derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | $0.00 derived: sum of 2 quarters · filed 2015-03-24 | $0.00 derived: sum of 3 quarters · filed 2015-03-24 | $0.00 10-K · filed 2015-03-24 |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-14 | $0.00 derived: sum of 2 quarters · filed 2014-11-14 | $0.00 10-Q · filed 2014-11-14 | |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 | $0.00 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |